Delivery of pharmaceutical products for treatment of oncological and hematological diseases and blood coagulation factors for the needs of UMBAL Dr. Georgi Stranski EAD - Pleven
Original notice title
Bulgaria – Pharmaceutical products – „Доставка на лекарствени продукти за лечение на онкологични и хематологични заболявания и фактори за кръвосъсирване за нуждите на УМБАЛ „Д-р Георги Странски” ЕАД - Плевен”
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
60 / 100
Risk factors
Structured data indicates EU funding, but XML notice states 'no-eu-funds'. This could affect contract terms or budget.
Requires specific wholesale and possibly manufacturer authorizations for each product, which may narrow the field of el...
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Strong opportunityKey Facts
- BGN 324.7M estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 1 lot
- Duration 36 MONTH
- Delivery of pharmaceutical products for oncology and hematology
- Delivery of blood coagulation factors
Show full summary
This is a restricted procedure for a Dynamic Purchasing System (DPS) for the supply of pharmaceutical products for oncological and hematological diseases and blood coagulation factors to the University Hospital Dr. Georgi Stranski in Pleven, Bulgaria. The estimated value is 324,733,078.61 BGN, with a duration of 36 months. The deadline for submission is 2028-05-02. The award is based on lowest price.
Risks
Structured data indicates EU funding, but XML notice states 'no-eu-funds'. This could affect contract terms or budget.
Requires specific wholesale and possibly manufacturer authorizations for each product, which may narrow the field of el...
Restricted procedure — pre-qualification required
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a registered trader permitted to wholesale medicinal products
- Must hold a wholesale authorization for medicinal products from the Bulgarian Drug Agency (IAL) or equivalent from another EU member state
- If manufacturer, must hold production authorization or authorization from the product manufacturer
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
гр. Плевен, BGR
Buyer profile
Identifier
114532352
Activity
Health
Lots (1)
LOT-0001
Delivery of pharmaceutical products for treatment of oncological and hematological diseases and blood coagulation factors for the needs of UMBAL Dr. Georgi Stranski EAD - Pleven
Supply of oncological and hematological medicines and blood clotting factors as per technical specifications. The lot is a DPS with continuous competition.
BGN 324.7M
Estimated value
Location
Duration
Category
Award Criteria
Deadline
Award details
На първо място се класира участникът, предложил най-ниска цена. Останалите оферти заемат места в класирането по низходящ ред
Value note
Show original TED data
Original lot title
„Доставка на лекарствени продукти за лечение на онкологични и хематологични заболявания и фактори за кръвосъсирване за нуждите на УМБАЛ „Д-р Георги Странски” ЕАД - Плевен”
Original TED description
Процедура по реда на Закона за обществените поръчки за лекарствени продукти за лечение на онкологични и хематологични и фактори за кръвосъсирване за нуждите на „УМБАЛ Д-р Георги Странски” ЕАД – Плевен,, по смисъла на Закона за лекарствените продукти в хуманната медицина , съгласно техническата спецификация и условията на настоящата документация.
Procurement Details
- Publication date
- 02 Apr 2025
- Languages
- Bulgarian
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 216830-2025
Documents (1)
Similar tenders
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Belgium – Pharmaceutical products – Antimycotica
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
60 / 100
Risk factors
Structured data indicates EU funding, but XML notice states 'no-eu-funds'. This could affect contract terms or budget.
Requires specific wholesale and possibly manufacturer authorizations for each product, which may narrow the field of el...
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications